IN188469B - - Google Patents

Info

Publication number
IN188469B
IN188469B IN420DE2000A IN188469B IN 188469 B IN188469 B IN 188469B IN 420DE2000 A IN420DE2000 A IN 420DE2000A IN 188469 B IN188469 B IN 188469B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Herve Bouchard
Alain Commercon
Original Assignee
Rohne Poulenc Rorer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohne Poulenc Rorer S A filed Critical Rohne Poulenc Rorer S A
Publication of IN188469B publication Critical patent/IN188469B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN420DE2000 1995-12-22 2000-04-10 IN188469B (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
IN188469B true IN188469B (en:Method) 2002-09-28

Family

ID=9485871

Family Applications (4)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (en:Method) 1995-12-22 1996-12-20
IN420DE2000 IN188469B (en:Method) 1995-12-22 2000-04-10
IN421DE2000 IN188470B (en:Method) 1995-12-22 2000-04-10
IN419DE2000 IN188680B (en:Method) 1995-12-22 2000-04-10

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN2893DE1996 IN186768B (en:Method) 1995-12-22 1996-12-20

Family Applications After (2)

Application Number Title Priority Date Filing Date
IN421DE2000 IN188470B (en:Method) 1995-12-22 2000-04-10
IN419DE2000 IN188680B (en:Method) 1995-12-22 2000-04-10

Country Status (40)

Country Link
US (1) US5728849A (en:Method)
EP (1) EP0876362B1 (en:Method)
JP (1) JP3953106B2 (en:Method)
KR (1) KR100500351B1 (en:Method)
CN (1) CN1103766C (en:Method)
AR (1) AR005197A1 (en:Method)
AT (1) ATE250593T1 (en:Method)
AU (1) AU712597B2 (en:Method)
BG (1) BG63204B1 (en:Method)
BR (1) BR9612135A (en:Method)
CA (1) CA2238884C (en:Method)
CO (1) CO4520184A1 (en:Method)
CZ (1) CZ294972B6 (en:Method)
DE (1) DE69630145T2 (en:Method)
DK (1) DK0876362T3 (en:Method)
DZ (1) DZ2149A1 (en:Method)
EA (1) EA001533B1 (en:Method)
ES (1) ES2202490T3 (en:Method)
FR (1) FR2742751B1 (en:Method)
HU (1) HU225032B1 (en:Method)
IL (1) IL124994A (en:Method)
IN (4) IN186768B (en:Method)
MA (1) MA26412A1 (en:Method)
MX (1) MX9804688A (en:Method)
MY (1) MY113934A (en:Method)
NO (1) NO317358B1 (en:Method)
NZ (1) NZ324337A (en:Method)
OA (1) OA10700A (en:Method)
PE (1) PE25198A1 (en:Method)
PL (1) PL189311B1 (en:Method)
PT (1) PT876362E (en:Method)
RO (1) RO116194B1 (en:Method)
SK (1) SK282835B6 (en:Method)
TN (1) TNSN96169A1 (en:Method)
TR (1) TR199801179T2 (en:Method)
TW (1) TW371659B (en:Method)
UA (1) UA48205C2 (en:Method)
UY (1) UY24386A1 (en:Method)
WO (1) WO1997023473A1 (en:Method)
ZA (1) ZA9610737B (en:Method)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
EP1165550A1 (en) 2000-02-02 2002-01-02 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes as antitumor agents
SK286975B6 (sk) * 2001-02-24 2009-08-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
NZ573360A (en) 2006-05-04 2012-08-31 Boehringer Ingelheim Int Polymorphic forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
MX2011001525A (es) * 2008-08-15 2011-03-29 Boehringer Ingelheim Int Derivados de purina para su uso en el tratamiento de enfermedades relacionadas con fab.
AU2009290911A1 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
US8865729B2 (en) 2008-12-23 2014-10-21 Boehringer Ingelheim International Gmbh Salt forms of a xanthine compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
WO2011064352A1 (en) 2009-11-27 2011-06-03 Boehringer Ingelheim International Gmbh Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
PH12012502162A1 (en) 2010-05-05 2013-02-04 Boehringer Ingelheim Int Combination therapy
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
PL2731947T3 (pl) 2011-07-15 2019-07-31 Boehringer Ingelheim International Gmbh Podstawiona dimeryczna pochodna chinazoliny, sposób jej wytwarzania i jej zastosowanie w kompozycjach farmaceutycznych do leczenia cukrzycy typu I i II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
JP6218811B2 (ja) 2012-05-14 2017-10-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Sirs及び/又は敗血症の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US10131682B2 (en) 2012-11-24 2018-11-20 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to a cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
DK3122757T3 (da) 2014-02-28 2023-10-09 Hangzhou Dac Biotech Co Ltd Ladede linkere og anvendelse deraf til konjugering
JP6615109B2 (ja) 2014-02-28 2019-12-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Dpp−4阻害薬の医学的使用
CA2991973C (en) 2015-07-12 2021-12-07 Suzhou M-Conj Biotech Co., Ltd. Bridge linkers for conjugation of a cell-binding molecule
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
NZ747331A (en) 2016-06-10 2025-06-27 Boehringer Ingelheim Int Gmbh Combinations of linagliptin and metformin
KR102459469B1 (ko) 2016-11-14 2022-10-26 항저우 디에이씨 바이오테크 씨오, 엘티디 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
EP0639186B1 (en) * 1992-04-17 1999-06-23 Abbott Laboratories Taxol derivatives
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
CZ196198A3 (cs) 1998-09-16
IN188470B (en:Method) 2002-09-28
HK1017895A1 (en) 1999-12-03
BG102569A (en) 1999-04-30
WO1997023473A1 (fr) 1997-07-03
PL189311B1 (pl) 2005-07-29
AU1180997A (en) 1997-07-17
DE69630145T2 (de) 2004-07-15
AR005197A1 (es) 1999-04-14
DE69630145D1 (de) 2003-10-30
JP3953106B2 (ja) 2007-08-08
EA001533B1 (ru) 2001-04-23
SK282835B6 (sk) 2002-12-03
RO116194B1 (ro) 2000-11-30
CZ294972B6 (cs) 2005-04-13
MY113934A (en) 2002-06-29
KR100500351B1 (ko) 2005-12-21
FR2742751B1 (fr) 1998-01-30
PE25198A1 (es) 1998-05-10
SK85398A3 (en) 1998-11-04
ATE250593T1 (de) 2003-10-15
MA26412A1 (fr) 2004-12-20
BG63204B1 (bg) 2001-06-29
MX9804688A (es) 1998-10-31
OA10700A (fr) 2002-11-27
DZ2149A1 (fr) 2002-10-23
FR2742751A1 (fr) 1997-06-27
UA48205C2 (uk) 2002-08-15
ES2202490T3 (es) 2004-04-01
IL124994A0 (en) 1999-01-26
HUP9904046A1 (hu) 2001-04-28
NZ324337A (en) 2000-03-27
TNSN96169A1 (fr) 2005-03-15
ZA9610737B (en) 1997-06-27
BR9612135A (pt) 1999-07-13
CA2238884C (fr) 2007-02-06
NO982580D0 (no) 1998-06-05
KR19990076680A (ko) 1999-10-15
IL124994A (en) 2000-12-06
CN1205697A (zh) 1999-01-20
NO317358B1 (no) 2004-10-18
EP0876362B1 (fr) 2003-09-24
CA2238884A1 (fr) 1997-07-03
PL327405A1 (en) 1998-12-07
HU225032B1 (en) 2006-05-29
US5728849A (en) 1998-03-17
CN1103766C (zh) 2003-03-26
UY24386A1 (es) 2001-08-27
IN188680B (en:Method) 2002-10-26
IN186768B (en:Method) 2001-11-03
AU712597B2 (en) 1999-11-11
TR199801179T2 (xx) 1998-10-21
EA199800588A1 (ru) 1998-12-24
TW371659B (en) 1999-10-11
DK0876362T3 (da) 2004-02-02
HUP9904046A3 (en) 2001-08-28
CO4520184A1 (es) 1997-10-15
PT876362E (pt) 2004-02-27
NO982580L (no) 1998-06-05
JP2000502671A (ja) 2000-03-07
EP0876362A1 (fr) 1998-11-11

Similar Documents

Publication Publication Date Title
DE69638352D1 (en:Method)
DE69637714D1 (en:Method)
IN186768B (en:Method)
EP0779527A3 (en:Method)
IN187706B (en:Method)
DK0727898T3 (en:Method)
IN183639B (en:Method)
DK126096A (en:Method)
ECSDI950246S (en:Method)
IN178814B (en:Method)
IN179491B (en:Method)
IN182078B (en:Method)
IN183430B (en:Method)
IN183732B (en:Method)
IN184885B (en:Method)
CN3036463S (en:Method)
CN3034473S (en:Method)
CN3037433S (en:Method)
CN3037189S (en:Method)
CN3036648S (en:Method)
CN3036647S (en:Method)
CN3037606S (en:Method)
CN3035871S (en:Method)
CN3035870S (en:Method)
CN3035869S (en:Method)